Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

The technique, which its creators call “direct imaging of neuronal activity” (DIANA), uses existing magnetic resonance imaging (MRI) technology to take series of quickfire, partial images, and then ...